PL330239A1 - Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment - Google Patents
Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatmentInfo
- Publication number
- PL330239A1 PL330239A1 PL97330239A PL33023997A PL330239A1 PL 330239 A1 PL330239 A1 PL 330239A1 PL 97330239 A PL97330239 A PL 97330239A PL 33023997 A PL33023997 A PL 33023997A PL 330239 A1 PL330239 A1 PL 330239A1
- Authority
- PL
- Poland
- Prior art keywords
- reserption
- growt
- coherent
- bone
- cyclic
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title 1
- 230000001427 coherent effect Effects 0.000 title 1
- 239000000470 constituent Substances 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK62396 | 1996-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL330239A1 true PL330239A1 (en) | 1999-05-10 |
Family
ID=8095682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL97330239A PL330239A1 (en) | 1996-05-31 | 1997-05-29 | Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0907374A1 (en) |
JP (1) | JP2000512274A (en) |
KR (1) | KR20000016204A (en) |
CN (1) | CN1220609A (en) |
AU (1) | AU3025997A (en) |
BR (1) | BR9709499A (en) |
CA (1) | CA2257174A1 (en) |
CZ (1) | CZ383298A3 (en) |
HU (1) | HUP9904049A3 (en) |
IL (1) | IL126983A0 (en) |
NO (1) | NO985573L (en) |
PL (1) | PL330239A1 (en) |
WO (1) | WO1997046252A1 (en) |
ZA (1) | ZA974785B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HN1996000101A (en) | 1996-02-28 | 1997-06-26 | Inc Pfizer | COMBINED THERAPY FOR OSTEOPOROSIS |
GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
JP4574849B2 (en) * | 1998-06-09 | 2010-11-04 | サファイア セラピューティクス,インコーポレイティド | Method for preparing compounds having growth hormone releasing properties |
US6784158B1 (en) | 1998-06-09 | 2004-08-31 | Novo Nordisk A/S | Method for preparing a compound with growth hormone releasing properties |
JP2001031635A (en) | 1999-07-14 | 2001-02-06 | Ajinomoto Co Inc | Production of optically active n-protected-n-methyl- phenylalanine derivative |
ES2333097T3 (en) | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | USE OF SECRETAGOGS OF GROWTH HORMONE TO STIMULATE GASTROINTESTINAL MOTILITY. |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
BRPI0807046A2 (en) | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Compound, pharmaceutical composition, methods of treating a disorder, cardiovascular disease and a patient suffering from reduced or dysfunctional gastrointestinal motility and, kit. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ236618A (en) * | 1990-01-03 | 1997-06-24 | Ciba Geigy Ag | Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound |
ATE150648T1 (en) * | 1990-11-26 | 1997-04-15 | Robert R Recker | TREATMENT OF OSTEOPOROSIS USING GROWTH HORMONE RELEASING FACTOR (GRF) IN CONJUNCTION WITH PARATHYROID HORMONE (PTH) |
BR9407869A (en) * | 1993-10-19 | 1996-10-29 | Merck & Co Inc | Combination of pharmaceutical composition and process for the treatment of osteoporosis |
-
1997
- 1997-05-29 KR KR1019980709772A patent/KR20000016204A/en not_active Application Discontinuation
- 1997-05-29 PL PL97330239A patent/PL330239A1/en unknown
- 1997-05-29 HU HU9904049A patent/HUP9904049A3/en unknown
- 1997-05-29 CA CA002257174A patent/CA2257174A1/en not_active Abandoned
- 1997-05-29 CN CN97195144A patent/CN1220609A/en active Pending
- 1997-05-29 BR BR9709499A patent/BR9709499A/en not_active Application Discontinuation
- 1997-05-29 IL IL12698397A patent/IL126983A0/en unknown
- 1997-05-29 AU AU30259/97A patent/AU3025997A/en not_active Abandoned
- 1997-05-29 CZ CZ983832A patent/CZ383298A3/en unknown
- 1997-05-29 EP EP97924934A patent/EP0907374A1/en not_active Withdrawn
- 1997-05-29 JP JP10500108A patent/JP2000512274A/en active Pending
- 1997-05-29 WO PCT/DK1997/000239 patent/WO1997046252A1/en not_active Application Discontinuation
- 1997-05-30 ZA ZA9704785A patent/ZA974785B/en unknown
-
1998
- 1998-11-27 NO NO985573A patent/NO985573L/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20000016204A (en) | 2000-03-25 |
CN1220609A (en) | 1999-06-23 |
IL126983A0 (en) | 1999-09-22 |
EP0907374A1 (en) | 1999-04-14 |
AU3025997A (en) | 1998-01-05 |
NO985573D0 (en) | 1998-11-27 |
BR9709499A (en) | 1999-08-10 |
WO1997046252A1 (en) | 1997-12-11 |
HUP9904049A2 (en) | 2000-04-28 |
HUP9904049A3 (en) | 2000-07-28 |
ZA974785B (en) | 1998-01-22 |
CA2257174A1 (en) | 1997-12-11 |
NO985573L (en) | 1999-01-29 |
JP2000512274A (en) | 2000-09-19 |
CZ383298A3 (en) | 1999-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0767624A4 (en) | Devices and methods for bone/tissue preparation | |
HUP0004170A3 (en) | Methods and materials for treating and preventing inflammation ofmucosal tissue | |
IL131543A0 (en) | Cosmetic methods and compositions for preventing and treating chronological aging in human skin | |
ZA976598B (en) | IGF-I and insulin formulation | |
IL125981A0 (en) | Improved tissue destruction in cryosurgery | |
EP1047442A4 (en) | Bone morphogenetic proteins and their use in bone growth | |
EP0955874A4 (en) | Method and device for stable impedance plethysmography | |
ZA947138B (en) | Skin care method and composition | |
PL332547A1 (en) | Skin care compositions containing an acid and retinoide | |
HU9801511D0 (en) | Human semaphorin-l (h-sema-l) and corresponding semaphorine in other species | |
GB2317182B (en) | Sulfated polysaccharides and uses thereof in medical treatment | |
PL330239A1 (en) | Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment | |
GB2325461B (en) | Medical sharps and blades removal and containment structure | |
IL111554A (en) | Methods and compositions for hair treatment | |
GB2317980B (en) | Analogue multiplier using MOSFETs in nonsaturation region and current mirror | |
ZA971718B (en) | Combination therapy to prevent bone loss-progesterone and estrogen agonists | |
GB9609944D0 (en) | An improvement in the treatment of wastes | |
AU135003S (en) | An abutment for use in dental implant | |
ZA976547B (en) | Lipid-binding proteins and their therapeutic and diagnostic use | |
ZA947145B (en) | Skin care method and composition | |
GB9614958D0 (en) | Cosmetic skin treatment and apparatus therefor | |
GB9617346D0 (en) | Therapeutic methods and compositions for use therein | |
GB2338231B (en) | Medical sharps and blades removal and containment structure | |
GB9210405D0 (en) | Improvements in and relating to surgical sutures | |
GB9620530D0 (en) | Back and neck treatment device |